Red Alert!! Read the box inserts from vaccine manufacturers @: ...

FLU SCAM.com - http://www.fluscam.com Here's some quotes from the inserts they have posted from the actual box inserts of the vaccines they're promoting that I've used to make the following fliers that I'm passing out:

WARNING! VACCINES CAN KILL YOU & SERIOUSLY HARM BABIES AND CHILDREN!

VACCINES ARE CAUSING PANDEMICS – WAKE UP!!

Read the following quoted material from package inserts supplied within the boxes of the H1N1 VACCINE by the companies making the vaccines for (in some cases) mandatory vaccination and innoculation in the U.S. (Full text Pdf. downloads @: www.FluScam.com)

HIDDEN IN PLAIN SIGHT! -- QUOTES FROM Sanofi-Pasteur PACKAGE INSERT:

“---------WARNINGS AND PRECAUTIONS--------”

(5.1) “Guillain-Barré Syndrome” and (5.2) Altered Immunocompetence”
(5.1) Recurrence of Guillain-Barré syndrome (GBS) has been temporally associated with the administration of influenza vaccine.” ... “If Guillain-Barré syndrome (GBS) has occurred within 6 weeks of previous influenza vaccination, the decision to give Influenza A (H1N1) 2009 Monovalent Vaccine should be based on careful consideration of the potential benefits and risks.” And ...

“Evidence for a causal relation of GBS with subsequent vaccines prepared from other influenza viruses is unclear” ...

(5.2) Immunocompromised persons may have a reduced immune response to Influenza A (H1N1) 2009 Monovalent Vaccine. ” ...If Influenza A (H1N1) 2009 Monovalent Vaccine is administered to immunocompromised persons, including those receiving immunosuppressive therapy, the immune response may be diminished.”

(6.1) “Clinical Trial Experience
Adverse event information from clinical trials provides the basis for identifying adverse events that appear to be related to vaccine use ... However, because clinical trials are conducted under widely varying conditions, ... the clinical trials of a vaccine cannot be directly compared to rates in the clinical trial of another vaccine, and may not reflect the rates observed in practice.”...

(6.2) “Post-Marketing Experience
“*Blood and Lymphatic System Disorders: Thrombocytopenia, lymphadenopathy Immune System Disorders: Anaphylaxis, other allergic/hypersensitivity reactions (including urticaria, angioedema) / Nervous System Disorders: GBS, convulsions, myelitis (including encephalomyelitis and transverse myelitis), facial palsy (Bell’s palsy), optic neuritis/neuropathy, brachial neuritis, syncope (shortly after vaccination), dizziness, paresthesia / Vascular Disorders: Vasculitis, vasodilation/flushing / Respiratory, Thoracic and Mediastinal Disorders: Dyspnea, pharyngitis, rhinitis / Skin and Subcutaneous Tissue Disorders: Stevens-Johnson syndrome / General Disorders and Administration Site Conditions: Fever, pain, pruritis, asthenia/fatigue, pain in extremities, chest pain” AND ...

“PREGNANCY”
Pregnancy Category C: Animal reproduction studies have not been conducted with Influenza A (H1N1) 2009 Monovalent Vaccine or Fluzone vaccine. *It is also not known whether these vaccines can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. Influenza A 2009 Monovalent Vaccine should be given to a pregnant woman only if clearly needed.”

a Nursing Mothers (8.3) “It is not known whether Influenza A (H1N1) 2009 Monovalent Vaccine or Fluzone vaccine is excreted in human milk.” a Pediatric Use (8.4) “Safety and effectiveness in pediatric subjects below the age of 6 months have not been established.” (emphasis added to all quotes)

**PLUS ... “The multi-dose presentation of Influenza A (H1N1) 2009 Monovalent Vaccine contains thimerosal, a mercury derivative, added as a preservative.” Mercury causes autism in children!!

“(11) DESCRIPTION” and “(13.1) Carcinogenesis, Mutagenesis, Impairment of Fertility
Influenza A (H1N1) 2009 Monovalent Vaccine, an inactivated influenza virus vaccine, for intramuscular use,...The virus-containing allantoic fluid is harvested and inactivated with formaldehyde.”

(13.1) “Neither Fluzone vaccine nor Influenza A (H1N1) 2009 Monovalent Vaccine ... [Neither] have been evaluated for carcinogenic or mutagenic potential, or for impairment of fertility.”

Fluvirin® NOVARTIS 2008 – 2009 VACCINE FORMULA PACKAGE INSERT: “WARNINGS AND PRECAUTIONS” - Sec. (5.1) - (5.4) “Limitations of Vaccine Effectiveness”

“If Guillain-Barré syndrome has occurred within 6 weeks of receipt of prior influenza vaccine, the decision to give FLUVIRIN® should be based on careful consideration of the potential benefits and risks.” (5.1) • “Immunocompromised persons may have a reduced immune response ...” and Section
(5.4) “Vaccination with FLUVIRIN® may not protect all individuals. ...”

“(6.4) Other Adverse Reactions Associated with Influenza Vaccination
Neurological disorders temporally associated with influenza vaccination such as encephalopathy, optic neuritis/neuropathy, partial facial paralysis, and brachial plexus neuropathy have been reported.

(8.4) “Pediatric Use” and “Fetal harm”
The safety and immunogenicity of FLUVIRIN® have not been established in children under 4 years of age.” **(Fetal harm) “It is also not known whether FLUVIRIN® can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity.”

(12) “CLINICAL PHARMACOLOGY” & (12.1) “Mechanism of Action”
Influenza illness and its complications follow infection with influenza viruses. “... post-vaccination with inactivated influenza virus vaccine have not been correlated with protection from influenza illness.” “Antibodies against one influenza virus type[/]subtype confers limited or no protection against another.” (emphasis mine)